Cronos Group (CVE:MJN) Stock Price Down 1.9% – Time to Sell?

Cronos Group Inc (CVE:MJN – Get Free Report)’s stock price was down 1.9% on Tuesday. The company traded as low as C$11.90 and last traded at C$12.15. Approximately 1,388,975 shares changed hands during trading, a decline of 33% from the average daily volume of 2,065,952 shares. The stock had previously closed at C$12.38.

Cronos Group Stock Performance

The firm’s 50 day moving average is C$12.15 and its two-hundred day moving average is C$12.15.

About Cronos Group

(Get Free Report)

Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada’s Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals.

See Also

• Five stocks we like better than Cronos Group
• Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
• Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
• Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
• Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.